(Q40213997)

18 September 2017

TIM-3 plays a more important role than PD-1 in the functional impairments of cytotoxic T cells of malignant Schwannomas (English)

1 reference

18 September 2017

Zhao Li

1

1 reference

18 September 2017

Xiaobing Liu

series ordinal

2

1 reference

18 September 2017

Rongbin Guo

series ordinal

3

1 reference

18 September 2017

Pengfei Wang

series ordinal

4

1 reference

18 September 2017

1 May 2017

1 reference

18 September 2017

1 reference

18 September 2017

39

1 reference

18 September 2017

5

1 reference

18 September 2017

1010428317698352

1 reference

Descriptive epidemiology of vestibular schwannomas

18 September 2017

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698352

Malignant transformation of a recurrent vestibular schwannoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698352

Survival in Malignant Peripheral Nerve Sheath Tumours: A Comparison between Sporadic and Neurofibromatosis Type 1-Associated Tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698352

Malignant transformation of a vestibular schwannoma after gamma knife radiosurgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698352

Rate of recurrent vestibular schwannoma after total removal via different surgical approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698352

Innate and adaptive immune cells in the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698352

CD4⁺ follicular helper T cell infiltration predicts breast cancer survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698352

Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698352

Elevated CD3+ and CD8+ tumor-infiltrating immune cells correlate with prolonged survival in glioblastoma patients despite integrated immunosuppressive mechanisms in the tumor microenvironment and at the systemic level

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698352

Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698352

CD8+ T-cell memory in tumor immunology and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698352

Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698352

B regulatory cells in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698352

Tumor microenvironment and lymphocyte infiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698352

Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698352

Coordinated regulation of myeloid cells by tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698352

Tregs and rethinking cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698352

Suppression of antitumor immunity by IL-10 and TGF-beta-producing T cells infiltrating the growing tumor: influence of tumor environment on the induction of CD4+ and CD8+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698352

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698352

Regulatory T cells and their roles in immune dysregulation and allergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698352

Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698352

PD-1 and its ligands in tolerance and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698352

Immunosuppressive strategies that are mediated by tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698352

Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698352

Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698352

Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698352

Galectin-1, -3 and -9 Expression and Clinical Significance in Squamous Cervical Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698352

Cell surface galectin-9 expressing Th cells regulate Th17 and Foxp3+ Treg development by galectin-9 secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698352

Re-adapting T cells for cancer therapy: from mouse models to clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698352

T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698352

B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698352

Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698352

IL-12 upregulates TIM-3 expression and induces T cell exhaustion in patients with follicular B cell non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698352

Antigen-independent induction of Tim-3 expression on human T cells by the common γ-chain cytokines IL-2, IL-7, IL-15, and IL-21 is associated with proliferation and is dependent on the phosphoinositide 3-kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698352

PD-1 blockade upregulate TIM-3 expression as a compensatory regulation of immune check point receptors in HNSCC TIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698352

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698352

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698352

Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317698352

21 January 2018

Identifiers

DOI

10.1177/1010428317698352

1 reference

18 September 2017

1 reference